University of Missouri School of Medicine pilots Roche’s cloud-based NAVIFY Tumor Board solution to streamline & standardize data collection and presentation, enabling faster, better collaboration among oncology care teams
To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 23
How cross-functional collaboration between academia and industry is advancing drug discovery in the ULTRA-DD program
SelectScience brings you scientific and technical takeaways from the 2018 AACR Annual Meeting
Which new product, instrument or consumable has made the most difference to your clinical lab or point-of-care practice? Nominate now for a chance to win a $500/£400/450€ Amazon voucher
Discover the cutting-edge ways science and technology are taking on infectious diseases to help make the future healthier
During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research
Team heading to Chicago, USA, to interview scientists at the forefront of cancer research and report on the newest technologies
Experts discuss the expanding role of mass spectrometry in forensic toxicology and drug monitoring research
From rhinos to chemical warfare agents, we bring you the latest in forensics and toxicology
How research at the AMR Centre, UK, is accelerating the fight against antimicrobial resistance
Discover 10 wonderful webinars popular with scientists across the globe in 2017 — and watch them on demand
Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth
An optimized, automated workflow enables continued growth of the clinical mass spectrometry service at this leading London Trust
Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute
Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix
Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease
Read exclusive interviews from experts in healthcare settings around the world, to discover how mass spectrometry is improving clinical diagnostics
Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research
Josh Haimes, technical lead at ArcherDX, explains how successful NGS is influenced by step-by-step quality control
Scientists across the world share their thoughts on the benefits of being a SelectScience member
Dr Alex Lawson, Principal Clinical Scientist, Birmingham Heartlands Hospital, discusses the use of inductively coupled plasma mass spectrometry in clinical science research
Detecting and minimizing pre-analytical variables in clinical analysis
Find out how smooth installation of the Beckman Coulter DxC 700 AU chemistry analyzer helped a busy clinical laboratory to improve patient care
